Klausen MK, Thomsen M, Wortwein G, Fink-Jensen A
But the resulting drugs and the process by which they are made aren't clinically tested, which is why the resulting drugs are not FDA-approved
Heres why this matters 1 First-Mover Advantage in a Blockbuster Molecule Ready to launch immediately upon patent expiry Early entry = potential market share dominance Targeting both Type-2 diabetes & obesity 2 Massive Price Disruption Expected Current therapy cost: 8,00016,000/month Expected generic pricing: 4,0005,000/month Industry estimates suggest prices may fall 5065% over time In a largely out-of-pocket market like India, price is access
Fayez A Quereshy, MD, MBA
If the solution is cloudy or has floating particles after 10 minutes, something went wrong